Endemic mycoses

1. Kauffman CA.  Central nervous system infection with other endemic mycoses: rare manifestation of blastomycosis, paracoccidioidomycosis, talaromycosis, and sporotrichosis.  J Fungi 2019:5;64  doi:10.3390/jof5030064
2. Kauffman CA.  Treatment of the midwestern endemic mycoses, blastomycosis and histoplasmosis.  Curr Fungal Infect Rep 2017:11:67–74.
3. Thompson III GR, Le T, Chindamporn A, et al.  Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European
   Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology.  Lancet Infect Dis 2021;21:364-74.

Blastomycosis

1. Bush JW, Wuerz T, Embil JM, et al.  Outcomes of persons with blastomycosis involving the central nervous system.  Diag Microbiol Infect Dis  2013;76:175–81.
2. Chapman SW, Bradsher RW, Campbell, Jr GD, et al.  Practice guidelines for the management of patients with blastomycosis.  Clin Infect Dis 2000;30:679-83.
3. Chapman SW, Dismukes WE, Proia LA, et al.  Clinical practice guidelines for the management of blastomycosis:  2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008;46:1801-12.
4. Linder KA, Kauffman CA, Miceli MH. Blastomycosis: a review of mycological and clinical aspects.  J Fungi 2023;9:117  https://doi.org/10.3390/jof9010117
5. McBride JA, Gauthier GM, Klein BS.  Clinical manifestations and treatment of blastomycosis.  Clin Chest Med 2017;38:435–49. doi:10.1016/j.ccm.2017.04.006

Coccidioidomycosis

1. Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) Clinical practice guideline for the treatment of
   coccidioidomycosis.  Clin Infect Dis 2016;63:e112-46.
2. Galgiani JN, Ampel NM, Blair JE, et al.  Coccidioidomycosis.  Clin Infect Dis 2005;41:1217-23.
3. Galgiani JN, Ampel NM, Catanzaro A, et al.  Practice guidelines for the treatment of coccidioidomycosis.  Clin Infect Dis 2000;30:658-61.

Histoplasmosis

1. Wheat LJ, Freifeld AG, Kleiman MB, et al.  Clinical practice guidelines for the management of patients with histoplasmosis:  2007 update by the Infectious Dieases Society of America.  Clin Infect Dis 2007:45:807-25.
2. Wheat J, Sarosi G, McKinsey D, et al.  Practice guidelines for the management of patients with histoplasmosis.  Clin Infect Dis 2000;30:688-95.

Paracoccidioidomycosis

1. Shikanai-Yasuda MA, Mendes RP, Colombo AL, et al.  Brazilian guidelines for the clinical management of paracoccidioidomycosis.  Rev Soc Bras Med Trop 2017;5:715-40.

Sporotrichosis

1. Kauffman CA, Bustamante B, Chapman SW, et al.  Clinical practice guidelines for the management of sporotrichosis:  2007 update by the Infectious Diseases Society of America.  Clin Infect Dis 2007;45:1255-65.
2. Kauffman CA, Hajjeh R, Chapman SW.  Practice guidelines for the management of patients with sporotrichosis.  Clin Infect Dis 2000; 30:684-7.Restrepo A, Robledo J, Gomez I, et al.  Itraconazole therapy in lymphangitic and cutaneous sporotrichosis.  Arch Dermatol 1986;122:413-7.
3. Orofino-Costa R, Freitas DFS, Bernardes-Engemann AR, et al.  Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management. Anais Brasileiros de Dermatologia 2022;97:757-77.
4. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al.  Treatment of sporotrichosis with itraconazole.  Am J Med 1993;95:279-85.

Talaromycosis